TY - JOUR
T1 - Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells
AU - Sepp-Lorenzino, Laura
AU - Eberhard, Inge
AU - Ma, Zhenping
AU - Cho, Cheryl
AU - Serve, Hubert
AU - Liu, Franklin
AU - Rosen, Neal
AU - Lupu, Ruth
PY - 1996
Y1 - 1996
N2 - Heregulins (HRGs) induce tyrosine phosphorylation of several members of the erb-B family of receptors. Although originally isolated as the ligands for p185(c-erbB-2), recent evidence suggests that other receptors of the erbB family, including p180(erbB-3) and p180(erbB-4), are their true cognate receptors. Stimulation of MDA MB-453 cells with HRGβ2 resulted in the tyrosine phosphorylation of p185(c-erbB-2), and p180(erbB-4) in a time-and dose-dependent fashion. This event was accompanied by the formation of multimeric complexes between the activated receptors and SH2-containing proteins. Ligand caused p120-rasGTPase activating protein (GAP), SHC and the p85 subunit of phosphatidylinositol-3'-kinase (PI3K) to be associated with both p185(c-erbB-2) and p180(erbB-4). In addition, tyrosine phosphorylation of p85-PI3K and SHC, but not of GAP or of its associated p62 and p190 proteins, was also detected. HRG also induced the association of GRB2 with tyrosine phosphorylated p185(c-erbB-2), p180(erbB-4) and SHC. Activation of mitogen-activated protein kinase (MAPR) (> 30-fold over untreated controls) was observed upon receptor(s) activation, as it was the induction of the immediate early gene c-fos (> 200-fold). These observations suggest that p21(ras) activation plays a role in the HRG pathway. Furthermore, comparative analysis of the binding of p85-PI3K to 185(c-erbB-2) and p180(erbB-4), revealed a preferential association with activated p180(erbB-4). These findings might suggest a model of HRG action in which the relative expression of the various erb-B family members and the partitioning of signal transduction molecules between each type of receptor might determine the nature of the signal elicited by the ligand and the biological response attained.
AB - Heregulins (HRGs) induce tyrosine phosphorylation of several members of the erb-B family of receptors. Although originally isolated as the ligands for p185(c-erbB-2), recent evidence suggests that other receptors of the erbB family, including p180(erbB-3) and p180(erbB-4), are their true cognate receptors. Stimulation of MDA MB-453 cells with HRGβ2 resulted in the tyrosine phosphorylation of p185(c-erbB-2), and p180(erbB-4) in a time-and dose-dependent fashion. This event was accompanied by the formation of multimeric complexes between the activated receptors and SH2-containing proteins. Ligand caused p120-rasGTPase activating protein (GAP), SHC and the p85 subunit of phosphatidylinositol-3'-kinase (PI3K) to be associated with both p185(c-erbB-2) and p180(erbB-4). In addition, tyrosine phosphorylation of p85-PI3K and SHC, but not of GAP or of its associated p62 and p190 proteins, was also detected. HRG also induced the association of GRB2 with tyrosine phosphorylated p185(c-erbB-2), p180(erbB-4) and SHC. Activation of mitogen-activated protein kinase (MAPR) (> 30-fold over untreated controls) was observed upon receptor(s) activation, as it was the induction of the immediate early gene c-fos (> 200-fold). These observations suggest that p21(ras) activation plays a role in the HRG pathway. Furthermore, comparative analysis of the binding of p85-PI3K to 185(c-erbB-2) and p180(erbB-4), revealed a preferential association with activated p180(erbB-4). These findings might suggest a model of HRG action in which the relative expression of the various erb-B family members and the partitioning of signal transduction molecules between each type of receptor might determine the nature of the signal elicited by the ligand and the biological response attained.
KW - Heregulin
KW - Signaling
KW - erbB receptors
UR - http://www.scopus.com/inward/record.url?scp=0029928763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029928763&partnerID=8YFLogxK
M3 - Article
C2 - 8622888
AN - SCOPUS:0029928763
SN - 0950-9232
VL - 12
SP - 1679
EP - 1687
JO - Oncogene
JF - Oncogene
IS - 8
ER -